Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,706.00
Bid: 2,704.00
Ask: 2,708.00
Change: -4.00 (-0.15%)
Spread: 4.00 (0.148%)
Open: 2,706.00
High: 2,720.00
Low: 2,688.00
Prev. Close: 2,710.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

9 Jul 2021 15:47

RNS Number : 8171E
Coca-Cola HBC AG
09 July 2021
 

 

 

Coca-Cola HBC AG

Conference call invitation for investors and analysts

2021 half-year results on Thursday, 12 August 2021

 

 

Zug, Switzerland - 9 July 2021 - Coca-Cola HBC AG (Coca‑Cola HBC) will release 2021 half-year results on Thursday, 12 August 2021 at 7:00 am BST. The press release will be available as of that time on the company's website: https://www.coca-colahellenic.com/en/investor-relations/results-reports-presentations

 

Coca-Cola HBC's management will host a conference call for investors and analysts on Thursday, 12 August 2021 at 9:00 am BST.

 

To join the call, in listen-only mode please join via webcast at:  http://coca-colahellenic.com/ 

 

If you anticipate asking a question, please dial one of the following numbers and quote 'Coca‑Cola Hellenic'. Please dial in 20 minutes early to allow the operator to manage demand in the current environment and to ensure that you are able to join the call at the start.

 

UK participants - toll free

0808 109 0700

US participants - toll free

1 866 966 5335

Greek participants - toll free

00800 1273 78

Swiss participants - toll free

0800 800 038

Standard international

+44 (0) 33 0551 0200

 

A recording of the call and its transcript will be made available on the Company's website following the conference call: https://www.coca-colahellenic.com/en/investor-relations/results-reports-presentations

 

 

 

 

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

Vasso Aliferi

Investor Relations Manager

 

Tel: +41 79 610 78 81

vasso.aliferi@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

 

 

 

 

About Coca-Cola HBC

Coca-Cola HBC is a growth-focused Consumer Packaged Goods business and strategic bottler of The Coca-Cola Company. The company creates value for all its stakeholders by supporting the socio-economic development of the societies in which it operates and believes that building a more positive environmental impact is integral to its future growth. Together, the company and its customers serve more than 600 million consumers across a broad geographic footprint of 28 countries on 3 continents. Its portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading partner brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These brands include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, Fuze Tea, Dobry, Cappy, Monster and Adez. Coca-Cola HBC fosters an open and inclusive work environment amongst its more than 27,000 employees and in November 2020 was rated Europe's most sustainable beverage company by the S&P DJSI for the 7th time in 8 years. The company currently holds the highest possible ratings in leading ESG benchmarks such as, CDP (Climate and Water), MSCI ESG and FTSE4Good.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit http://www.coca-colahellenic.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORSSLFLUEFSELW
Date   Source Headline
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights
19th May 201712:24 pmRNSDirector/PDMR Shareholding
16th May 20177:11 amRNSNotice of AGM
15th May 20177:23 amRNSchange to the Board and confirms dividend dates
11th May 20177:00 amRNSYEAR STARTS WELL WITH GOOD REVENUE GROWTH
2nd May 20179:07 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.